Table 2.

Assessment of parameters of inflammationa

 Salineb LPSb Eta + LPS GTN + LPS NP Saline NP LPS 
No. of WBCc 3.52 (1.4–4.6)h 6.29 (3.4–8.5) 4.03 (1.3–5.8)e 3.06 (1.2–5.9)h 3.55 (2.5–4.8)g 2.23 (1.1–3)h 
No. of monocytesc 0.31 (0.1–0.6)e 0.57 (0.2–1.0) 0.31 (0.1–0.5)e 0.25 (0.1–0.5)g 0.42 (0.2–0.6) 0.2 (0.1–0.3)e 
No. of granulocytesc 2.2 (1.0–2.9)h 4.1 (2.2–5.7) 2.76 (0.9–3.9)e 2.06 (0.8–3.1)h 1.55 (1.4–1.8)i 1.2 (0.4–1.8)i 
No. of lymphocytesc 1.01 (0.3–1.6)f 1.61 (0.7–2.6) 0.95 (0.3–1.4)f 0.75 (0.3–1.4)e 1.58 (0.9–2.7) 0.83 (0.4–0.9)f 
No. of animals (CBC analysis) 10 11 
No. animals (TNF analysis) 
Plasma TNF (pg/ml)d undetectable (0) 1285 (0–33643)k 2132 (0–8377.2)j 111.1 (0–127.3) undetectable (0) 61.05 (0–240.8) 
 Salineb LPSb Eta + LPS GTN + LPS NP Saline NP LPS 
No. of WBCc 3.52 (1.4–4.6)h 6.29 (3.4–8.5) 4.03 (1.3–5.8)e 3.06 (1.2–5.9)h 3.55 (2.5–4.8)g 2.23 (1.1–3)h 
No. of monocytesc 0.31 (0.1–0.6)e 0.57 (0.2–1.0) 0.31 (0.1–0.5)e 0.25 (0.1–0.5)g 0.42 (0.2–0.6) 0.2 (0.1–0.3)e 
No. of granulocytesc 2.2 (1.0–2.9)h 4.1 (2.2–5.7) 2.76 (0.9–3.9)e 2.06 (0.8–3.1)h 1.55 (1.4–1.8)i 1.2 (0.4–1.8)i 
No. of lymphocytesc 1.01 (0.3–1.6)f 1.61 (0.7–2.6) 0.95 (0.3–1.4)f 0.75 (0.3–1.4)e 1.58 (0.9–2.7) 0.83 (0.4–0.9)f 
No. of animals (CBC analysis) 10 11 
No. animals (TNF analysis) 
Plasma TNF (pg/ml)d undetectable (0) 1285 (0–33643)k 2132 (0–8377.2)j 111.1 (0–127.3) undetectable (0) 61.05 (0–240.8) 
a

WBC, white blood cells; NP, non-pregnant.

b

Some data are represented in Fig. 1, B–D.

c

CBCs were performed on GD 17.5, 24 h after the last LPS injection. Data are expressed as mean (range).

d

Plasma was collected 2 h after saline/LPS administration to NP animals or 2 h after saline/LPS administration to pregnant animals on GD 13.5. Data are represented as median (range).

e

P < 0.1 versus LPS.

f

P < 0.05 versus LPS.

g

P < 0.01 versus LPS.

h

P < 0.001 versus LPS.

i

P < 0.0001 versus LPS.

j

P < 0.05 versus saline.

k

P < 0.01 versus saline.

or Create an Account

Close Modal
Close Modal